PUBLIC EXPOSE

PT DARYA-VARIA LABORATORIA TBK

Hotel Fairmont, 7 Mei 2018
Jakarta 1
 Topik / Topics :
1. Tinjauan Pasar
Market Overview
2. Sekilas tentang DVL
DVL at a Glance
3. Tinjauan Bisnis DVL Tahun 2017
DVL Business Overview FY 2017
4. Kinerja DVL Kuartal 1-2018
2
DVL Performance 1st Q-2018
TINJAUAN
PASAR
MARKET OVERVIEW

3
 Kondisi Umum
General Conditions
7

6.5
Emerging market World Indonesia
6

5.5
5.0 5.0 5.1
5,07
5
4.8

4.5 4.3 4.3

4
Perekonomian Indonesia tumbuh 5,07%
3.5
3.6
3
3.5 3.4 Indonesia’s economy grew by 5.07%
3.2
2.5

2014 2015 2016 2017

Sebagaimana dilaporkan oleh Badan Pusat Statistik (BPS), 2017:

 Pendapatan Domestik Bruto (PDB) Rp13.588,8 triliun
 PDB per kapita sebesar Rp51,89 juta atau USD 3.876,8
 Komponen konsumsi rumah tangga berkontribusi 56,13%
 Belanja pemerintah berkontribusi 9,10%
As reported by Central Statistics Agency (BPS), 2017:
 Gross Domestic Product (GDP) Rp13,588.8 trillion
 GDP per capita Rp51.89 million or USD 3,876.8.
 Household consumption contributed 56.13%
 Government consumption 9.10% 4
 Kondisi Umum
General Conditions

Stabilitas makroekonomi terjaga dengan baik:

- inflasi 3,61%
- nilai tukar Rp13.548 per dolar AS

Macroeconomic stability was well-maintained:

- inflation at 3.61%
- exchange rate closed 2017 at Rp13.548 to the US dollar

5
 Kondisi Umum
General Conditions
Perkembangan yang mempengaruhi industri farmasi:
Developments that impacted the pharmaceutical industry:

 Peningkatan cakupan Program Jaminan Kesehatan Nasional (JKN) yang

diselenggarakan BPJS Kesehatan hingga 70% penduduk Indonesia
National Health Insurance (NHI) program by BPJS Kesehatan, increased
its coverage to about 70% of Indonesian citizens

 Semakin dekatnya penerapan untuk kriteria halal

Impending implementation of halal compliance

 Pengetatan peraturan oleh Badan Pengawas Obat dan Makanan

(BPOM) Nasional
Tightened regulations by the National Agency of Food & Drug Control
(BPOM)
6
 SEKILAS
TENTANG DVL
D V L AT A G L A N C E

7
8
9
 Segmen Bisnis Utama
Main Business Segments

Bisnis Ekspor
Bisnis Obat Resep Bisnis Consumer Health
Prescription Business Consumer Health Business & Jasa Toll Manufacturing
Export & Toll Manufacturing Business

10
 Fasilitas Produksi
Production Facilities

Citeureup, Bogor Gunung Putri, Bogor

Produk Steril & Padat Kapsul Lunak, Cairan, Kosmetik
Sterile & Solid Soft Capsule, Liquid, Cosmetic

11
IKHTISAR
DVL
DVL HIGHLIGHTS

12
 Peluncuran Produk Baru
New Products Launch

MARCH 2017 OCTOBER 2017

DIPITENZ PROTEZID

APRIL 2017
IAL SYSTEM NOVEMBER 2017
ESOZID 13
 Kegiatan Pemasaran
Marketing Activities

PR & On-Ground Activation

Scientific Seminars

Medical Science Centre

Digital Marketing

14
TINJAUAN BISNIS
DVL TAHUN 2017
DVL BUSINESS OVERVIEW
F Y 2 0 17

15
 Kinerja DVL Tahun 2017
DVL Performance FY 2017

Penjualan Bersih (Net Sales) Pertumbuhan

(Miliar/Billion Rupiah) (Growth)

Bisnis Obat Resep 537 12%

(Prescription Business)

Bisnis Kesehatan Konsumen 746 14%

(Consumer Health Business)

Bisnis Ekspor & Jasa Toll Manufacturing 292 (8%)

(Export & Toll Manufacturing Business)

Jumlah Penjualan Bersih / Total Net Sales 1.575 8,6%

16
 LAPORAN LABA RUGI
STATEMENT OF PROFIT OR LOSS

Uraian 2017 2016

% Pertumbuhan Description
(dalam miliar Rupiah) % Growth (in billion Rupiah)

Laba Bruto 894 801 12% Gross Income

Laba Usaha 220 204 8% Operating Income

Laba Bersih 162 152 7% Net Income

Marjin Laba Bersih 10% 10% - Net Income Margin

Laba bersih per saham Net Income per Share

(Rupiah penuh)
145 136 7%
(full rupiah)

17
 LAPORAN POSISI KEUANGAN
STATEMENT OF FINANCIAL POSITION

Uraian Increase/ Description

2017 2016
(dalam miliar Rupiah) (Decrease) (in billion Rupiah)

Total Aset 1.641 1.531 7% Total Assets

Aset Lancar 1.176 1.069 10% Current Assets

Total Liabilitas 525 452 16% Total Liabilities

Ekuitas 1.116 1.080 3% Equity

18
 LAPORAN ARUS KAS
STATEMENT OF CASH FLOWS

Uraian Increase/ Description

2017 2016
(dalam miliar Rupiah) Decrease (in billion Rupiah)

Arus kas dari Cash flows from

231 187 23%
operasional operations
Arus kas untuk Cash flows used in
(41) (197) (79%)
aktivitas investasi investing activities

Arus kas untuk Cash flows used in

(112) (39) 187%
aktivitas pendanaan financing activities

19
 KINERJA DVL
KUARTAL 1-2018
DVL PERFORMANCE
1 s t Q - 2 01 8

20
 Kinerja Kuartal 1-2018
Q1 2018 Performance

I. Total Penjualan Bersih DVL sebesar Rp 430

I. Total DVL Net Sales at Rp 430 bio
miliar
- DVL grew by 8%
- DVL tumbuh sebesar 8%
II. Apa yang mendukung kinerja bisnis? II. What drove the business?
- Pertumbuhan Bisnis Obat Resep +20%
- Prescription Business +20% growth
- Pertumbuhan Ekspor dan Jasa Toll
Manufacturing +22% - Export and Toll Manufacturing +22% growth

III. Tantangan bisnis III. Business challenges

- Menurunnya industri farmasi - Pharma industry in declined
- Consumer Health -7% - Consumer Health -7%

IV. Keuangan : IV. Financials :

- Laba Bruto, Laba Usaha & Laba Bersih DVL - DVL Gross Income, Operating Income &
tetap terjaga Net Profit are on track

V. Program Sampai Dengan Akhir Tahun yang

V. Balance Year Program in place
terencana 21
 DVL PUBLIC EXPOSE

SESI
TANYA JAWAB
QUESTIONS AND ANSWERS

22
23